drugset
drugset / Trial / NCT01908595

Long Term Study to Evaluate Safety and Efficacy of M518101 in Subjects With Plaque Psoriasis

NCT01908595 ↗

Phase 3 Completed 480 enrolled Maruho North America Inc.
Non-randomizedSingle-groupOpen-labelTreatment

Summary

This study is to evaluate the efficacy and safety for long term use of M518101 in subjects with plaque psoriasis.

Timeline

Start
2013-08
Primary completion
2015-05
Completion
2015-05

Drugs

EvaluationDrugModalityDoseRoute
Subject pefcalcitol Small molecule — —

Indications

psoriasis